Found: 1
Select item for more details and to access through your institution.
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1484, doi. 10.1007/s10637-011-9733-2
- By:
- Publication type:
- Article